Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
absence, Alpha, antibody, attention, Bio, biopharmaceutical, bispecific, Blossom, breach, Carcinoma, cell, chairman, committee, contemplated, court, covenant, Cytovia, Daniel, Decathlon, diligence, director, diversion, dividend, Dr, eighty, enjoining, factor, forma, Hepatocellular, illegal, immune, incapable, incomplete, injunction, interim, justify, Lender, merge, merged, merger, Myeloma, NAYA, newly, oncology, Orange, penalty, pending, permanently, premium, prepaid, prohibiting, prohibition, provisional, purport, recapitalization, receipt, refinanced, refinancing, regenerative, rejected, repayment, representation, reserved, RLSA, RSLA, sending, standstill, stop, successfully, surviving, suspending, Teper, thirty, threatened, triangular, true, unanticipated, waived, waiver, warranty, weekly, York
Removed:
commercially, COVID, intention, ramp, review, startup, Tampa
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view